- Home
- NVNO vs APM Comparison
NVNO vs APM Comparison
Compare NVNO & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- APM
- Stock Information
- Founded
- NVNO 1987
- APM 2010
- Country
- NVNO United States
- APM United Kingdom
- Employees
- NVNO N/A
- APM N/A
- Industry
- NVNO Medical/Dental Instruments
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- NVNO Health Care
- APM Health Care
- Exchange
- NVNO Nasdaq
- APM Nasdaq
- Market Cap
- NVNO 16.7M
- APM 18.9M
- IPO Year
- NVNO N/A
- APM 2018
- Fundamental
- Price
- NVNO $0.71
- APM $1.48
- Analyst Decision
- NVNO
- APM
- Analyst Count
- NVNO 0
- APM 0
- Target Price
- NVNO N/A
- APM N/A
- AVG Volume (30 Days)
- NVNO 331.1K
- APM 420.2K
- Earning Date
- NVNO 10-31-2025
- APM 01-01-0001
- Dividend Yield
- NVNO N/A
- APM N/A
- EPS Growth
- NVNO N/A
- APM N/A
- EPS
- NVNO N/A
- APM N/A
- Revenue
- NVNO N/A
- APM N/A
- Revenue This Year
- NVNO N/A
- APM N/A
- Revenue Next Year
- NVNO N/A
- APM N/A
- P/E Ratio
- NVNO N/A
- APM N/A
- Revenue Growth
- NVNO N/A
- APM N/A
- 52 Week Low
- NVNO $0.67
- APM $0.46
- 52 Week High
- NVNO $5.62
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- NVNO 32.52
- APM 41.59
- Support Level
- NVNO $0.68
- APM $1.43
- Resistance Level
- NVNO $0.76
- APM $1.59
- Average True Range (ATR)
- NVNO 0.06
- APM 0.17
- MACD
- NVNO 0.03
- APM -0.03
- Stochastic Oscillator
- NVNO 16.45
- APM 10.95
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.